Q4 2024 Earnings Call Transcript February 13, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported ...
Health and Human Services Secretary Robert F. Kennedy Jr. said any staffers in the department who are “working for the ...
PM; the BSE Smallcap and BSE Midcap indices were down 3.1% and 2.3%, respectively, as against 0.3% decline in the BSE Sensex.
Prime Bank PLC recently signed an agreement with Healthcare Pharmaceuticals Limited to provide comprehensive cash management ...
CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a ...
Farallon presses Astellas to cut costs and overhaul drugs research in latest shareholder campaign gripping Tokyo ...
The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...
Doximity reported strong Q3 performance, driven by high pharma client demand. Click here to find out why DOCS stock has been ...
As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nineteen analysts that are covering the firm, Ratings reports. Eight research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results